MSB 2.29% $1.07 mesoblast limited

Cell Therapy News/Articles, page-17679

  1. 280 Posts.
    lightbulb Created with Sketch. 311
    It’s clear to me how Dr. Perin would have had a strong influence on the agenda, that being promoting cell therapy as a breakthrough . I just wish that Dr. Rose might eventually fill the last speaking spot, and that it would be just after FDA agreed with the company a pathway for both LVAD and HLHS approval.
    Last edited by irenekwshiu: 01/05/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.025(2.29%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.10 $1.10 $1.06 $4.942M 4.613M

Buyers (Bids)

No. Vol. Price($)
6 70659 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 43531 2
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.